A Study of Sotatercept for the Treatment of Pulmonary Arterial
https://clinicaltrials.gov/ct2/show/NCT04576988
Oct 06, 2020 · This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, parallel-group study in subjects with symptomatic Pulmonary Arterial Hypertension (PAH) who present with idiopathic or heritable PAH, PAH associated with connective tissue diseases (CTD), drug or toxin induced, post shunt correction PAH, or PAH presenting at least 1 year following …
DA: 96 PA: 47 MOZ Rank: 86